Inhaler trial aims to reduce lung damage in smokers

Young smokers are being sought to take part in a product trial that may slow lung decline The GSK-funded trial, being run by The George Institute for Global Health, is recruiting people aged 25-45 with the aim to try and slow down lung function decline in smokers, and reduce rates of chronic bronchitis and emphysema.